ASH: rilzabrutinib demonstrated significant patient benefit in the first positive phase 3 study of a BTK inhibitor in ITP Pivotal phase 3 data ...

During August 2021 to August 2023, the overall prevalence of anemia was 9.3% among people aged 2 years and older.

During August 2021 to August 2023, the overall prevalence of anemia was 9.3 percent among people aged 2 years and older, ...

researchers conclude that some patients with preoperative anemia have better outcomes if they get iron infusions before ... After Major Traumatic Brain Injury, More Blood Transfusions Could Mean ...

[47] Therefore, in all cancer patients with any degree of anemia, it is important to investigate whether there is iron deficiency. If the parameters indicate low levels of ferritin, TfSat or CHr ...

Promising topline results from a phase 3B study show the efficacy and quality of life (QOL) improvements of iptacopan ...

Novel triple-drug therapies are showing promise for patients with various kinds of leukemia, researchers reported at the ...

British drugmaker GSK said on Monday its experimental cancer drug Blenrep in combination with other treatments reduced the ...

Women should have the option of taking their own test samples for cervical cancer screening, an influential health panel said ...

Interim analysis from Phase 1a portion of KOMET-007 shows 100% CR rate in NPM1-m and 83% CR rate in KMT2A-r 1L adverse risk AML with 7+3 – – 100% of 1L NPM1-m and 96% of 1L KMT2A-r AML patients alive ...

Researchers at University of California San Diego School of Medicine and their colleagues have developed the first ...